Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.9B | 6.3B | 7.8B | 8.2B |
Cost of revenue | 7.2B | 5.7B | 6.9B | 7.1B |
Gross profit | 750.8M | 607.4M | 924.5M | 1.1B |
Operating expense | ||||
Research & development | 252.8M | 224.7M | 218.3M | 182.5M |
Selling general and admin | 182.8M | 180.2M | 197.5M | 185.1M |
Other operating expenses | — | — | — | — |
Operating income | 315.1M | 202.5M | 508.6M | 702.6M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 30.7M | 18.5M | 9.0M | 23.9M |
Other income expense | 22.9M | -25.3M | 17.9M | 10.0M |
Pretax income | 307.3M | 158.8M | 517.5M | 688.6M |
Tax provision | 26.6M | 8.1M | 78.6M | 103.1M |
Net income | 269.3M | 150.1M | 442.4M | 585.5M |
Basic EPS | — | 0.0 | 0.1 | 0.2 |
Diluted EPS | — | 0.0 | 0.1 | 0.2 |
Basic average shares | — | 3.3B | 3.2B | 3.2B |
Diluted average shares | — | 3.4B | 3.5B | 3.5B |
EBITDA | 363.8M | 192.1M | 547.0M | 732.0M |
Net income from continuing op. | 269.3M | 150.1M | 442.4M | 585.5M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |